Browsing by Author "S Chan"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Pembrolizumab 400 mg every 6 weeks as firstline therapy for advanced melanoma KEYNOTE555 Results from cohort B of an openlabel phase 1 stud(PUBLIC LIBRARY SCIENCE) G Cohen; B Rapoport; S Chan; Paul Ruff; A Arance; E et al